Home Newsfeeds JP Morgan Maintains Neutral on Conagra Brands, Raises Price Target to $43

JP Morgan Maintains Neutral on Conagra Brands, Raises Price Target to $43

JP Morgan analyst Ken Goldman maintains Conagra Brands (NYSE:CAG) with a Neutral and raises the price target from $38 to $43.

byBenzinga Newsdesk

January 6, 2023

1 minute read

JP Morgan analyst Ken Goldman maintains Conagra Brands (NYSE:CAG) with a Neutral and raises the price target from $38 to $43.

News

‘Jack Ma’s Office Says He Remains ‘very Positive’ About Alibaba And Clarifies That He Will Continue To Hold The Tech Giant’s Shares’ – SCMP

By Benzinga Newsdesk

November 17, 9:02 AM

https://www.scmp.com/business/companies/article/3241971/jack-mas-office-says-he-remains-very-positive-about-alibaba-and-clarifies-he-will-continue-hold-tech?module=latest&pgtype=homepageJack Ma's office said the

BABA

Analyst Ratings

Analyst Ratings for Angi

By Benzinga Insights

February 10, 1:01 PM

Over the past 3 months, 4 analysts have published their opinion on Angi (NASDAQ:ANGI) stock. These analysts are…

ANGI

Ionis Pharmaceuticals’ Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action

By Vandana Singh

September 26, 12:57 PM

Ionis Pharmaceuticals Inc (NASDAQ: IONS) released topline results for the Phase 3 Balance study of olezarsen in people with familial chylomicronemia syndrome (FCS), a hereditary disease that prevents the body from breaking down fats.

IONS